Sort
8,912 grants matching “sars cov 2”
Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms
$769,918Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · MH
Mucosal subunit vaccines against SARS CoV-2
$769,833Purnima Dubey · Ohio State University · R01 · FY2024 · AI
Effect of obesity and diabetes in regulating pulmonary and extra-pulmonary anti-viral immune responses
$769,522Kamal Mohan Khanna · New York University School Of Medicine · R01 · FY2024 · DK
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
$769,010Yi Shi · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
COVID-19 Mother Baby Outcomes (COMBO): brain-behavior functioning
$768,912Dani Dumitriu · Columbia University Health Sciences · R01 · FY2024 · MH
Novel delivery platform and antigen design for an effective COVID-19 vaccine
$768,884Suresh K Mittal · Purdue University · R01 · FY2022 · AI
Evolution and Clinical Relevance of SARS-CoV-2 Variants in West Virginia
$768,858Sally Lynn Hodder · West Virginia University · U54 · FY2022 · GM
Novel diagnostic tools and animal model system for study human/animal interface of COVID-19
$768,711Ying Fang · University Of Illinois At Urbana-Champaign · R01 · FY2023 · AI
REstoring mental health after COVID-19 through commUnity-based Psychological services in New York City (RECOUP-NY)
$768,515Brandon Alan Kohrt · George Washington University · R01 · FY2021 · MH
Role and Mitigation of Inflammasomes and Inflammation During COVID-19
$768,215Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R56 · FY2021 · AI
Mechanisms of atherosclerotic cardiovascular complications in COVID19
$768,169Chiara Giannarelli · New York University School Of Medicine · R01 · FY2024 · HL
Establishing critical time windows of infant RSV infection in the causal relationship of RSV and childhood asthma
$767,578Pingsheng Wu · Vanderbilt University Medical Center · R01 · FY2025 · HL
Using Disadvantage Indices in Pandemic Vaccine Allocation and Beyond to Promote Health Opportunity
$767,180Thomas Harald Schmidt · University Of Pennsylvania · R01 · FY2025 · AI
Research Employing Environmental Systems and Occupational Health Policy Analyses to Interrupt the Impact of Structural Racism on Agricultural Workers and Their Respiratory Health (RESPIRAR)
$767,058Devon C Payne-Sturges · Univ Of Maryland, College Park · R01 · FY2022 · ES
Discovery of Antivirals Targeting Mpox Virus
$767,057Stefan G Sarafianos · Emory University · R01 · FY2025 · AI
Risk Factors for AIDS among Persons Who Inject Drugs: HIV and COVID-19
$767,023Don C Des Jarlais · New York University · R01 · FY2023 · DA
Community-based Design and Evaluation of a Conversational Agent to Promote SARS-COV2 Vaccination in Black Churches
$766,758Timothy W Bickmore · Northeastern University · R01 · FY2021 · MD
Mechanism and Inhibition of SARS-CoV-2 Entry
$766,721Sean P. J. Whelan · Washington University · R01 · FY2021 · AI
Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2
$766,651Robert Virgil Stahelin · Purdue University · R01 · FY2023 · AI
Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery
$766,601James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Long-term Neuropsychiatric Sequelae of SARS-CoV-2 Infection in Late Life
$766,195Amy Lynn Byers · Northern California Institute/Res/Edu · R01 · FY2023 · AG
Revising Anti-coronavirus Compounds to Enhance Activity and Optimize Delivery
$766,165Robert Turner Schooley · University Of California, San Diego · R01 · FY2021 · AI
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross
$766,144Mark T Heise · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross
$766,144Mark T Heise · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross
$766,144Mark T Heise · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI